New Coverage – PreveCeutical Medical (PRVCF)

PreveCeutical Medical is biomedical company focused on preventative health sciences using organic and nature-identical compounds.  The Company was recently organized to pursue market opportunities for a novel therapy based on blue scorpion venom.  PreveCeutical markets an  CELLB9, an oral solution of blue scorpion venom for use without prescription.  The solution has been found instrumental in […]

Read More

Updated Coverage – Moxian, Inc. (MOXC)

Our coverage is updated of Moxian, Inc., the most recent entrant into China’s thriving online-to-offline e-commerce market.  Following report of quarter financial results, we spoke at length with Moxian’s chief executive officer James Mengdong Tan regarding the Company’s plans for market penetration and recent strategic developments.  The group has shifted its approach to bring the […]

Read More

Coverage Update – Moxian, Inc. (MOXC)

We have updated our coverage of Moxian, Inc. (MOXC) developer of the Moxian+ online-to-offline (O2O) platform for small- and medium-sized businesses in China.  The Company reports results reflecting the receipt and initial deployment of proceeds from its $10 million common stock offering in November 2016.  Our financial model has been updated to reflect recent financial performance […]

Read More